Expression and Clinical Significance of Ki-67, CD10, BCL6, MUM1, c-MYC, and EBV in Diffuse Large B Cell Lymphoma Patients.

Alireza SadeghipourSeyed Reza TahaMahdieh Shariat ZadehFarid KosariPegah BabaheidarianFahimeh FattahiNavid AbdiFatemeh Tajik

Published in: Applied immunohistochemistry & molecular morphology : AIMM (2024)

Collectively, this study's results add these markers' value to the existing clinical understanding of DLBCL. However, further investigations are needed to explore markers' prognostic and biological roles in DLBCL patients.

Keyphrases

diffuse large b cell lymphoma
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
poor prognosis
squamous cell carcinoma
radiation therapy
patient reported outcomes